Thursday, July 17, 2008

Clinical trial to test vitamin C against non-Hodgkin lymphoma

Researchers at Thomas Jefferson University Hospital and the Kimmel Cancer Center in Philadelphia, in collaboration with the National Institutes of Health, are initiating a trial to test the effects of high dose vitamin C in patients with non-Hodgkin's lymphoma (NHL). The study will be the first to test the effects of the vitamin when administered intravenously to NHL patients.

A team led by Daniel Monti, MD, who is the director of the Myrna Brind Center of Integrative Medicine at Thomas Jefferson, plans to enroll twenty patients for whom standard non-Hodgkin lymphoma therapy has been unsuccessful. Trial participants will receive varying doses of intravenous vitamin C three times per week while being monitored for disease progression. Continue Reading

No comments: